Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Chest|July 11, 2003
New choices for central venous catheters: potential financial implicationsAndrew F Shorr, Christopher W Humphreys, Donald L HelmanRespiration; International Review of Thoracic Diseases|March 20, 2004
Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitisRussell M Peckham, Andrew F Shorr, Donald L HelmanChest|March 10, 2004
Sarcoidosis, race, and short-term outcomes following lung transplantationAndrew F Shorr, Donald L Helman, Darcy B Davies, et al.Chest|September 13, 2002
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromesDonald L Helman, John C Byrd, Noel C Ales, et al.Chest|May 17, 2007
Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trialsDonald L Helman, Alexander W Brown, Jeffrey L Jackson, et al.Chest|May 13, 2005
Outcomes and safety of surgical lung biopsy for interstitial lung diseaseChristopher J Lettieri, Ganesh R Veerappan, Donald L Helman, et al.Critical Care Medicine|September 23, 2003
Effect of standardized orders and provider education on head-of-bed positioning in mechanically ventilated patientsDonald L Helman, John H Sherner, Thomas M Fitzpatrick, et al.Chest|October 16, 2004
Depreotide scanning in sarcoidosis: a pilot studyAndrew F Shorr, Donald L Helman, Christopher J Lettieri, et al.Respirology (Carlton, Vic.)|October 8, 2003
Management of idiopathic pulmonary haemosiderosis in pregnancy: report of two casesDonald L Helman, Anthony Sullivan, Steven T Kariya, et al.Respiration; International Review of Thoracic Diseases|February 12, 2004
Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysisSteven D Nathan, Scott D Barnett, Brian Moran, et al.Pageof 1